Answers are grounded in this paper and cite their sources.
NF-kappaB transcription factors and the signaling pathways that activate them play a critical role in cancer development, progression and therapy, and recently have become a focal point for intense drug discovery and development efforts. This article presents a critical review on the different types of inhibitors targeting the NF-kappaB pathway at several stages.
No takes yet. Share an insight, caveat, or question.
Melisi et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: